JPMorgan Upgrades Novartis (NVS) to Overweight
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $152.32 --0%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 9
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 9
Join SI Premium – FREE
JPMorgan upgraded Novartis (NYSE: NVS) from Neutral to Overweight.
For an analyst ratings summary and ratings history on Novartis click here. For more ratings news on Novartis click here.
Shares of Novartis closed at $85.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Akamai Technologies (AKAM) to Neutral 'on Account of Confidence in Revenue Reacceleration'
- Citi upgrades Establishment Labs to Buy with $92 target
- JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
Create E-mail Alert Related Categories
Hot Upgrades, Trader Talk, UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
